216 related articles for article (PubMed ID: 17923842)
1. Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea.
Johnson LN; Cashman SM; Kumar-Singh R
Mol Ther; 2008 Jan; 16(1):107-14. PubMed ID: 17923842
[TBL] [Abstract][Full Text] [Related]
2. Nuclear targeted delivery of macromolecules to retina and cornea.
Binder C; Read SP; Cashman SM; Kumar-Singh R
J Gene Med; 2011 Mar; 13(3):158-70. PubMed ID: 21344542
[TBL] [Abstract][Full Text] [Related]
3. Cell penetrating peptide POD mediates delivery of recombinant proteins to retina, cornea and skin.
Johnson LN; Cashman SM; Read SP; Kumar-Singh R
Vision Res; 2010 Mar; 50(7):686-97. PubMed ID: 19733192
[TBL] [Abstract][Full Text] [Related]
4. Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Corneal Epithelium Using a Modified Cell-Penetrating Peptide.
Schiroli D; Gómara MJ; Maurizi E; Atkinson SD; Mairs L; Christie KA; Cobice DF; McCrudden CM; Nesbit MA; Haro I; Moore T
Mol Ther Nucleic Acids; 2019 Sep; 17():891-906. PubMed ID: 31476668
[TBL] [Abstract][Full Text] [Related]
5. In Silico Ocular Pharmacokinetic Modeling: Delivery of Topical FK962 to Retina.
Mori A; Yabuta C; Kishimoto Y; Kozai S; Ohtori A; Shearer TR; Azuma M
J Ocul Pharmacol Ther; 2017 Sep; 33(7):556-566. PubMed ID: 28598703
[TBL] [Abstract][Full Text] [Related]
6. Discerning the composition of penetratin for safe penetration from cornea to retina.
Jiang K; Gao X; Shen Q; Zhan C; Zhang Y; Xie C; Wei G; Lu W
Acta Biomater; 2017 Nov; 63():123-134. PubMed ID: 28927928
[TBL] [Abstract][Full Text] [Related]
7. Rapid assessment of ocular drug delivery in a novel ex vivo corneal model.
Begum G; Leigh T; Courtie E; Moakes R; Butt G; Ahmed Z; Rauz S; Logan A; Blanch RJ
Sci Rep; 2020 Jul; 10(1):11754. PubMed ID: 32678110
[TBL] [Abstract][Full Text] [Related]
8. Cell penetrating peptides in ocular drug delivery: State of the art.
Pescina S; Ostacolo C; Gomez-Monterrey IM; Sala M; Bertamino A; Sonvico F; Padula C; Santi P; Bianchera A; Nicoli S
J Control Release; 2018 Aug; 284():84-102. PubMed ID: 29913221
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an ex vivo model implication for carrier-mediated retinal drug delivery.
Kansara V; Mitra AK
Curr Eye Res; 2006 May; 31(5):415-26. PubMed ID: 16714233
[TBL] [Abstract][Full Text] [Related]
10. The use of cell-penetrating peptides as a tool for gene regulation.
Järver P; Langel U
Drug Discov Today; 2004 May; 9(9):395-402. PubMed ID: 15081956
[TBL] [Abstract][Full Text] [Related]
11. Effect of eye pigmentation on transscleral drug delivery.
Cheruvu NP; Amrite AC; Kompella UB
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):333-41. PubMed ID: 18172110
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable Nanoparticles Based on Pseudo-Proteins Show Promise as Carriers for Ophthalmic Drug Delivery.
Zhang W; Kantaria T; Zhang Y; Kantaria T; Kobauri S; Tugushi D; Brücher V; Katsarava R; Eter N; Heiduschka P
J Ocul Pharmacol Ther; 2020; 36(6):421-432. PubMed ID: 32639222
[No Abstract] [Full Text] [Related]
13. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
[TBL] [Abstract][Full Text] [Related]
14. Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells.
Rennert R; Neundorf I; Jahnke HG; Suchowerskyj P; Dournaud P; Robitzki A; Beck-Sickinger AG
ChemMedChem; 2008 Feb; 3(2):241-53. PubMed ID: 18205166
[TBL] [Abstract][Full Text] [Related]
15. Retina expression and cross-species validation of gene silencing by PF-655, a small interfering RNA against RTP801 for the treatment of ocular disease.
Lee DU; Huang W; Rittenhouse KD; Jessen B
J Ocul Pharmacol Ther; 2012 Jun; 28(3):222-30. PubMed ID: 22304497
[TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of histidine-rich amphipathic peptides for siRNA delivery.
Langlet-Bertin B; Leborgne C; Scherman D; Bechinger B; Mason AJ; Kichler A
Pharm Res; 2010 Jul; 27(7):1426-36. PubMed ID: 20393870
[TBL] [Abstract][Full Text] [Related]
17. Solubility, stability, physicochemical characteristics and in vitro ocular tissue permeability of hesperidin: a natural bioflavonoid.
Majumdar S; Srirangam R
Pharm Res; 2009 May; 26(5):1217-25. PubMed ID: 18810327
[TBL] [Abstract][Full Text] [Related]
18. Improving corneal permeability of dexamethasone using penetration enhancing agents: First step towards achieving topical drug delivery to the retina.
Thareja A; Leigh T; Hakkarainen JJ; Hughes H; Alvarez-Lorenzo C; Fernandez-Trillo F; Blanch RJ; Ahmed Z
Int J Pharm; 2024 Jun; ():124305. PubMed ID: 38852749
[TBL] [Abstract][Full Text] [Related]
19. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
Li J; Tan G; Cheng B; Liu D; Pan W
Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
[TBL] [Abstract][Full Text] [Related]
20. Sustained Subconjunctival Delivery of Infliximab Protects the Cornea and Retina Following Alkali Burn to the Eye.
Zhou C; Robert MC; Kapoulea V; Lei F; Stagner AM; Jakobiec FA; Dohlman CH; Paschalis EI
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):96-105. PubMed ID: 28114570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
